… papillary thyroid carcinoma (PTC) with clinically evident lateral cervical lymph node metastases
(cN1b… Controlled clinical trials assessing therapeutic effects and safety of PCND for cN1b …

… We reviewed and collected clinical and pathological records for 954 papillary thyroid carcinoma
patients with clinically positive lateral neck node metastasis. Univariate and multivariate …

… in thyroid cancer research, which indicates that a small subset of CSCs existed in tumor cells
… of CD44, CD24 and CD133 tumor cells in papillary thyroid carcinoma (PTC) as marker of …

… factors are important predictors of prognosis for papillary thyroid carcinoma (PTC), but their
… clinical N1b (cN1b) PTC. Methods: Patients who underwent surgery for cN1b PTC from 2013 …

… of the cancer stem cell (CSC) model has been heralded as a new era in thyroid cancer … the
presence of CD44+ and CD24‑tumor cells in papillary thyroid carcinoma (PTC) as markers of …

… papillary thyroid carcinoma (PTC) without clinical evidence of lateral neck metastasis (cN1b). …
the risk factors for lateral neck recurrence after the definitive treatment of PTC without cN1b. …

… The rate of recurrence was low (~5%) even in men, patients ≥55 years [30], patients with
tumors >2 cm, multicentric tumors or cN1b, and those with three LNM or LNM ≥10 mm. This …

SciELO - Brasil - Surgical treatment of pediatric and adolescent papillary thyroid cancer: a
retrospective study of 54 patients in a single center Surgical treatment of pediatric and …

… function but also improves neck dissection for cN0 stage papillary thyroid carcinoma(PTC).
However,impact of using CNP for cN1b stage PTC is still unknown. This study explored utility …

… as patients presenting with clinically significant lateral lymphadenopathy (cN1b). Prior
analysis of the outcomes of this cohort is largely from papillary thyroid cancer (PTC) (>1 cm) or …